Record check
Did the record support “US FDA extends review of Capricor's muscle disorder therapy by three months”?
Evidence state
developing
A dated primary-source record, attributable response, or correction that confirms, narrows, or resolves: US FDA extends review of Capricor's muscle disorder therapy by three months.
Receipts
- captured headline
US FDA extends review of Capricor's muscle disorder therapy by three months
This page is a source-linked record. It does not score a person, infer motive, or replace the preserved source material.